The US FDA has approved the first genetically modified plant intended for the treatment of a human disease?
~ The Rebel ~
2012/05/20 16:29:43
Story at-a-glance
- The US FDA has approved the first genetically modified plant intended for the treatment of a human disease. The drug, designed to treat Gaucher disease, contains human enzymes grown in carrot cells
- The approval opens the door for biotech companies such as Monsanto, which also has vested interests in the pharmaceutical industry, to design more drugs created from genetically engineered plants and/or animals
- Connecticut is the second state in five weeks to drop a GMO labeling provision in proposed legislation after Monsanto threatened to sue if lawmakers passed the bill. Last month Vermont succumbed to the same strong-arm tactics
- California is now the new battleground, where 90 percent of California voters favor labeling of genetically engineered foods, and where labeling advocates recently delivered one million signatures to place Right to Know Genetically Engineered Food Act on the Ballot for November 6. The Money Bomb Against Monsanto campaign aims to raise one million dollars to get the Act voted into law
Read More: http://articles.mercola.com/sites/articles/archive...
Sort By
- Woody 2012/05/20 16:35:21
On December 1, 2011, Rainbow Papaya from Hawaii will be fully approved for commercial shipments to Japan. This announcement marks the end of a long and tedious approval process which started in 1999, and the beginning of a new chapter for Hawaiian papaya growers. The approval of biotech papaya is significant because it is the first horticultural product, and the first direct-to-consumer food product to gain regulatory approval in Japan. The degree of acceptance of this product at the consumer level will serve as a leading indicator for numerous biotech products that are in the developmental and regulatory pipeline.reply
